切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2026, Vol. 20 ›› Issue (05) : 393 -396. doi: 10.3877/cma.j.issn.1674-0785.2026.05.008

综述

毗邻重要解剖结构肿瘤不可逆电穿孔的应用与进展
冀博荣, 邓伟, 闫诺, 张英霞()   
  1. 010050 呼和浩特,内蒙古医科大学附属医院超声医学科
  • 收稿日期:2026-04-21 出版日期:2026-05-30
  • 通信作者: 张英霞
  • 基金资助:
    内蒙古医学科学院公立医院科研联合基金项目(2024GLL40349)

Irreversible electroporation for tumors in proximity to vital anatomical structures: current applications and future directions

Borong Ji, Wei Deng, Nuo Yan, Yingxia Zhang()   

  1. Department of Ultrasound Medicine, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2026-04-21 Published:2026-05-30
  • Corresponding author: Yingxia Zhang
引用本文:

冀博荣, 邓伟, 闫诺, 张英霞. 毗邻重要解剖结构肿瘤不可逆电穿孔的应用与进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(05): 393-396.

Borong Ji, Wei Deng, Nuo Yan, Yingxia Zhang. Irreversible electroporation for tumors in proximity to vital anatomical structures: current applications and future directions[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(05): 393-396.

不可逆电穿孔是基于高强度短脉冲电场的非热消融技术,近年来在复杂部位肿瘤治疗中备受关注。对于毗邻重要血管、胆道、神经等关键结构的肿瘤,传统手术创伤大、风险高,热消融则受热损伤及热沉效应影响,疗效与安全性受限。而IRE通过诱导细胞膜不可逆损伤清除局部病灶,同时较好保留脉管结构,在胰头区、肝门区、肾门及前列腺等复杂解剖部位展现出独特优势。近年来研究提示,IRE还可能通过诱导免疫原性细胞死亡并重塑肿瘤微环境,增强抗肿瘤免疫应答。本文综述了不可逆电穿孔(IRE)的作用机制、技术优势、在不同复杂部位肿瘤中的疗效与安全性,以及当前挑战与未来发展方向。

Irreversible electroporation (IRE) is a non-thermal ablation modality that employs high-intensity, short-pulsed electric fields to induce irreversible cell membrane damage. It has garnered increasing attention for the treatment of tumors located in anatomically complex locations. For tumors adjacent to critical structures such as major blood vessels, bile ducts, and nerves, conventional surgery often entails substantial trauma and elevated perioperative risks, whereas thermal ablation is constrained by the risk of collateral thermal injury and the heat sink effect, which may compromise both therapeutic efficacy and patient safety. In contrast, IRE slectively eliminates local lesions through permanent membrane permeabilization while preserving the integrity of vascular and ductal structures, thereby offering distinct advantages in challenging regions including the pancreatic head, hepatic hilum, renal hilum, and prostate. Moreover, emerging evidence suggests that IRE may potentiate anti-tumor immune responses by inducing immunogenic cell death and remodeling the tumor microenvironment. This review summarizes the mechanisms of action, technical advantages, clinical efficacy and safety of IRE in tumors arising from various complex anatomical sites, and also discusses current challenges and future directions for this promising technique.

1
Jacobs EJ, Rubinsky B, Davalos RV. Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications [J]. Radiol Oncol, 2025, 59(1): 1-22.
2
陈夏怡, 周玲燕, 陈晨, 等. 甲状腺微小乳头状癌消融治疗的现状及进展[J]. 中国临床研究, 2023, 36(11): 1613-1618.
3
O'Neill CH, Tan M, Yan J, et al. Perioperative systemic immunophenotype following irreversible electroporation (IRE) predicts recurrence [J]. Am J Cancer Res, 2022, 12(1): 165-175.
4
Zhang N, Li Z, Han X, et al. Irreversible electroporation: an emerging immunomodulatory therapy on solid tumors [J]. Front Immunol, 2022, 12: 811726.
5
李明, 王辉阳, 陈强, 等. 不可逆电穿孔结合免疫治疗在胰腺癌中的应用进展 [J/OL]. 中华医学超声杂志(电子版), 2025, 22(4): 374-378.
6
He C, Sun S, Zhang Y, et al. The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the Hmgb1-rage-mapk axis in pancreatic cancer [J]. Oncoimmunology, 2021, 10(1): 1897295.
7
Wu Z, Shan Q, Jiang Y, et al. Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer [J]. Cancer Lett, 2025, 617: 217620.
8
贺艳华, 谭明英. 不可逆电穿孔技术治疗胰腺癌的研究进展 [J]. 中国普外基础与临床杂志, 2025, 32(6): 786-792.
9
李茂全. 晚期胰腺癌介入治疗临床操作指南(试行)(第六版) [J]. 临床肝胆病杂志, 2022, 38(6): 1242-1251.
10
Xu K, Chen Y, Su J, et al. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma [J]. J Cancer Res Ther, 2020, 16(2): 280-285.
11
Belfiore MP, De Chiara M, Reginelli A, et al. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it [J]. Front Oncol, 2022, 12: 943176.
12
王小雯, 赵建军. 不可逆电穿孔治疗肝门区域肿瘤的优势 [J]. 肝癌电子杂志, 2023, 10(1): 31-34.
13
Yun JH, Fang A, Khorshidi F, et al. New developments in image-guided percutaneous irreversible electroporation of solid tumors [J]. Curr Oncol Rep, 2023, 25(11): 1213-1226.
14
Imran KM, Brock RM, Beitel-White N, et al. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model [J]. Front Immunol, 2024, 15: 1352821.
15
Jeon SM, Davaa E, Jiang Y, et al. Assessment of hepatic lesions after non-thermal tumor ablation by irreversible electroporation in a pig model [J]. Technol Cancer Res Treat, 2023, 22: 15330338221147122.
16
Hogenes AM, Overduin CG, Slump CH, et al. The influence of irreversible electroporation parameters on the size of the ablation zone and thermal effects: a systematic review [J]. Technol Cancer Res Treat, 2023, 22: 15330338221125003.
17
Kihara M, Miyauchi A, Fujishima M, et al. Recurrent laryngeal nerve's course running anteriorly to a thyroid tumor [J]. Thyroid Res, 2023, 16(1): 30.
18
Liddy W, Wu CW, Dionigi G, et al. Varied recurrent laryngeal nerve course is associated with increased risk of nerve dysfunction during thyroidectomy: results of the surgical anatomy of the recurrent laryngeal nerve in thyroid surgery study, an international multicenter prospective anatomic and electrophysiologic study of 1000 monitored nerves at risk from the International Neural Monitoring Study Group [J]. Thyroid, 2021, 31(11): 1730-1740.
19
张会单, 常莹, 王一帆, 等. 超声引导下射频消融治疗甲状腺峡部微小乳头状癌与外科疗效的观察研究 [J]. 中国超声医学杂志, 2026, 42(3): 273-277.
20
岳文文, 董刚, 任志刚, 等. 超声引导下国产纳秒刀消融治疗甲状腺微小乳头状癌 [J]. 中国介入影像与治疗学, 2023, 20(11): 641-644.
21
岳文文, 司倩倩, 董刚. 超声引导下纳秒刀消融猪甲状腺 [J]. 中国介入影像与治疗学, 2023, 20(4): 250-251.
22
李室霖, 郭祖金, 赵旭, 等. 不可逆电穿孔技术及其在泌尿系恶性肿瘤中的应用进展 [J]. 大连医科大学学报, 2025, 47(2): 157-163, 168.
23
Wang Z, Huang W, Liu J, et al. Percutaneous irreversible electroporation of renal cell carcinomas in an acquired solitary kidney: a primary study [J]. J Cancer Res Ther, 2024, 20(7): 1997-2003.
24
中国医药教育协会介入微创治疗专业委员会. 影像学引导下不可逆电穿孔消融治疗肾癌专家建议(2023版) [J]. 中华医学杂志, 2023, 103(3): 167-170.
25
魏颖恬, 肖越勇, 王忠敏. 影像学引导下不可逆电穿孔消融治疗肝脏恶性肿瘤专家共识(2022版) [J]. 中国介入影像与治疗学, 2022, 19(5): 257-262.
26
简士博, 黄引, 曹德宏, 等. 肾肿瘤局灶治疗的研究进展 [J]. 现代泌尿外科杂志, 2025, 30(11): 955-959.
27
Prabhakar P, Avudaiappan AP, Sandman M, et al. Irreversible electroporation as a focal therapy for localized prostate cancer: a systematic review [J]. Indian J Urol, 2024, 40(1): 6-16.
28
靳晓旭, 赵晓东, 许松. 不可逆电穿孔治疗局限性前列腺癌的研究进展 [J]. 中华男科学杂志, 2025, 31(1): 76-80.
29
柏靖星, 黄引, 曹德宏, 等. 前列腺癌局灶治疗的研究进展 [J]. 中华男科学杂志, 2024, 30(3): 272-276.
30
Schmid BP, Mariotti GC, Miranda GM, et al. Irreversible electroporation for prostate cancer: another promising focal therapy [J]. Einstein (Sao Paulo), 2024, 22: eRC0779.
31
Savvides E, Pyrgidis N, Langas G, et al. Concomitant endoscopic surgery for bladder tumors and prostatic obstruction: are we safely hitting two birds with one stone? a systematic review and meta-analysis [J]. J Clin Med, 2022, 11(20): 6208.
32
Fainberg J, Lee T, Vertosick EA, et al. Targeted ablation using ultrasound-guided irreversible electroporation of index tumors (TARGET study): prospective development study evaluating safety, patient-reported outcomes, and oncologic efficacy [J]. Urol Pract, 2024, 11(6): 983-990.
33
Geboers B, van der Lei S, Kloppenborg LT, et al. Transcatheter CT arteriography-guided irreversible electroporation of locally advanced pancreatic adenocarcinoma: a pictorial essay [J]. J Med Imaging Radiat Oncol, 2023, 67(4): 428-434.
34
Spiers HVM, Lancellotti F, de Liguori Carino N, et al. Irreversible electroporation for liver metastases from colorectal cancer: a systematic review [J]. Cancers, 2023, 15(9): 2428.
35
Scrofani AR, Valvano M, Lancellotta V, et al. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis [J]. Br J Radiol, 2024, 97(1160): 1413-1422.
[1] 张娟敏, 王海, 曹弋娜, 曾欣, 查湘军, 刘莹, 周鸿, 周洋. 响应性纳米平台联合高强度聚焦超声增强三阴乳腺癌铁死亡及免疫治疗的研究[J/OL]. 中华医学超声杂志(电子版), 2026, 23(01): 67-76.
[2] 李琚, 陈强, 张洵, 谢丽婷, 蒋天安. 新型微纳秒脉冲电场消融仪器的研发及动物实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(12): 1124-1131.
[3] 钱舒然, 谭婧文, 王萌婕, 张思航, 杨镇英, 何越峰, 李晖. 致癌相关环状RNA在慢性乙型肝炎病毒感染者的表达及临床意义[J/OL]. 中华实验和临床感染病杂志(电子版), 2021, 15(02): 78-85.
[4] 李晓亮, 樊立茂, 郭朝卫, 王新刚. 单孔胸腔镜下肺段切除与肺亚段切除治疗早期非小细胞肺癌的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(06): 845-848.
[5] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[6] 郝卓伦, 齐雯丽, 孙家明, 周牧冉, 郭能强. 脂肪干细胞促进慢性创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2022, 12(04): 237-242.
[7] 全宗宗, 张进, 秦一雨. 蛋白乳酸化修饰及其在肝胆胰肿瘤中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(04): 648-652.
[8] 李卓群, 任冯刚, 王荣峰, 张东, 耿智敏, 吕毅, 仵正. 胆管癌局部治疗技术应用进展[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 153-156.
[9] 苏丽娅, 林满霞, 陈泽斌, 谢晓燕, 匡铭. 超声引导下纳米刀治疗不可切除的局部进展期胰腺癌[J/OL]. 中华肝脏外科手术学电子杂志, 2019, 08(03): 230-233.
[10] 王乾宇, 郭寒川, 吴斌. 瘤内菌群在结直肠癌中的作用研究进展[J/OL]. 中华结直肠疾病电子杂志, 2025, 14(04): 370-374.
[11] 曹奕强, 王永刚, 龙江. 肿瘤治疗电场治疗胶质母细胞瘤的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2020, 10(04): 234-238.
[12] 王亚婷, 邓伟, 张英霞. 甲状腺结节非高温热消融治疗的现状及进展[J/OL]. 中华临床医师杂志(电子版), 2026, 20(01): 58-61.
[13] 郎旭, 曾嘉. 不可逆电穿孔联合化疗治疗Ⅳ期胰腺癌的临床疗效和可行性分析[J/OL]. 中华介入放射学电子杂志, 2025, 13(03): 217-221.
[14] 刘红怡, 文烈伟, 占美晓, 陆骊工. 纳米材料在肿瘤微波诊疗中的研究进展[J/OL]. 中华介入放射学电子杂志, 2021, 09(02): 210-214.
[15] 欧范妍, 郭乾, 曾莉雄, 陈秋莉, 甘厚玉, 杨洁. 基于机器学习和转录组学综合分析线粒体自噬和铁死亡关键基因在成人脓毒症诱导ARDS中的免疫调控作用机制[J/OL]. 中华卫生应急电子杂志, 2025, 11(02): 86-101.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?